757 related articles for article (PubMed ID: 10438978)
21. The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage.
Bloom DD; St Clair EW; Pisetsky DS; Clarke SH
Eur J Immunol; 1994 Jun; 24(6):1332-8. PubMed ID: 8206093
[TBL] [Abstract][Full Text] [Related]
22. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
[TBL] [Abstract][Full Text] [Related]
23. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
Fatenejad S; Brooks W; Schwartz A; Craft J
J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
[TBL] [Abstract][Full Text] [Related]
24. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.
Cohen MG; Pollard KM; Schrieber L
Clin Exp Immunol; 1988 Apr; 72(1):50-4. PubMed ID: 3260838
[TBL] [Abstract][Full Text] [Related]
25. Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions.
Puccetti A; Migliorini P; Sabbaga J; Madaio MP
J Immunol; 1990 Dec; 145(12):4229-37. PubMed ID: 2258615
[TBL] [Abstract][Full Text] [Related]
26. Anti-nRNP anti-nuclear antibody-secreting cells are represented in the B-lymphocyte repertoire of normal and MRL/MP-lpr/lpr lupus mice.
Brennan FM; Andrew EM; Williams DG; Maini RN
Immunology; 1988 Feb; 63(2):213-7. PubMed ID: 3258271
[TBL] [Abstract][Full Text] [Related]
27. Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity.
Pisetsky DS; Hoch SO; Klatt CL; O'Donnell MA; Keene JD
J Immunol; 1985 Dec; 135(6):4080-5. PubMed ID: 3877763
[TBL] [Abstract][Full Text] [Related]
28. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
29. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
30. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
31. Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies.
Stocks MR; Williams DG; Maini RN
Clin Exp Immunol; 1987 Mar; 67(3):492-9. PubMed ID: 3496996
[TBL] [Abstract][Full Text] [Related]
32. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
33. T-B collaboration in the in vitro anti-Sm autoantibody response of MRL/Mp-lpr/lpr mice.
Shores EW; Eisenberg RA; Cohen PL
J Immunol; 1988 May; 140(9):2977-82. PubMed ID: 2966204
[TBL] [Abstract][Full Text] [Related]
34. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
35. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
36. Anti-P autoantibody production requires P1/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice.
Hines JJ; Weissbach H; Brot N; Elkon K
J Immunol; 1991 May; 146(10):3386-95. PubMed ID: 2026870
[TBL] [Abstract][Full Text] [Related]
37. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
Rodgers KE
J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
[TBL] [Abstract][Full Text] [Related]
38. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
39. VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. J558 bias is not limited to classic lupus autoantibodies.
Foster MH; MacDonald M; Barrett KJ; Madaio MP
J Immunol; 1991 Sep; 147(5):1504-11. PubMed ID: 1908876
[TBL] [Abstract][Full Text] [Related]
40. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
Kinoshita K; Tesch G; Schwarting A; Maron R; Sharpe AH; Kelley VR
J Immunol; 2000 Jun; 164(11):6046-56. PubMed ID: 10820290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]